Amid increasing economic tensions with the United States, China recently announced that it would ban Illumina, a U.S.-based company and the ...

The San Diego company also lowered its financial guidance for 2025 in response to China’s import restrictions.

Mammalian genomes are organized by multi-level folding, yet how this organization contributes to cell type-specific transcription remain unclear. We uncovered that the nuclear protein SATB1 ...

Illumina, Inc. ("Illumina" or the "company") today responded to the March 4, 2025 notice from the China Ministry of Commerce ("MOFCOM") that Illumina is not permitted to export sequencing instruments ...

GlobalData’s senior medical analyst says the ban will add to a downward trend for Illumina in the Chinese market.

The Chinese government took its economic sanctions against San Diego-based Illumina a step further Tuesday by banning the ...

Illumina navigates competition and geopolitical risks with improved margins and strong cash flow. Read my analysis of ILMN ...

Kokoris came up with the idea of solving some of the noise issue of nanopore sequencing by converting DNA into larger ...

Shares of Illumina (NASDAQ:ILMN) fell more than 4% in premarket trading on Tuesday after China imposed an immediate ban on the import of its gene sequencing instruments, escalating tensions in the ...

Investing.com -- Chinese stocks related to genetic sequencing experienced gains after Beijing implemented a ban on the import of machines from Illumina (NASDAQ: ILMN ), a US-based company. This move ...

China accounts for approximately 7% of Illumina’s sales. Gene sequencers are crucial for determining the sequence of DNA or ...